Dr. Robert Lee Brownlow Jr., MD

Dr. Brownlow practices at Cape Fear Retinal Associates in Wilmington, North Carolina.

Dr. Brownlow's NPI, 1568425403, was assigned on April 11, 2006. Dr. Brownlow graduated from Wake Forest School of Medicine in 1985. Dr. Brownlow's North Carolina license number on file is 9400211.

Dr. Brownlow's primary practice is Cape Fear Retinal Associates, at 1104 Medical Center Dr, Wilmington, NC 28401 in New Hanover County. The practice phone is (910) 332-3560.

Dr. Brownlow's primary practice is Cape Fear Retinal Associates in Wilmington, North Carolina. Dmand AI also links Dr. Brownlow to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brownlow practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Brownlow's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Brownlow is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Brownlow's licenses on file in 3 states: North Carolina, Virginia and New York.

Dmand AI lists age-related macular degeneration, cataract, dry eye, eye infection or inflammation, glaucoma, hereditary corneal conditions, hypertensive retinopathy and inflammation of iris among the conditions Dr. Brownlow treats.

CMS data shows 38,157 Medicare services from Dr. Brownlow across 17 procedure codes in 2024, for 1,056 Medicare patients. Medicare paid $2,848,671 for them. Every service was in an office.

CMS counts 1,056 Medicare patients who saw Dr. Brownlow in 2024. The largest group is 75 to 84, with 434 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brownlow's median patient age at 76, with 59% women.

In 2024, Dr. Brownlow wrote 135 Medicare Part D claims for 78 patients. 67% of them were for generic drugs. CMS names the drug for 113 of them, across 3 drugs with 11 or more claims each, at $2,777 in total drug cost. In 2023, CMS named 126 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Brownlow for performance year 2024, reported as part of a group. Dr. Brownlow accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 84 general payments to Dr. Brownlow from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Genentech, Inc. paid the most, $634.

Dmand AI lists 2 awards for Dr. Brownlow, most recently CMS Stage 1 2012 in 2012.

Dr. Brownlow graduated from Wake Forest School of Medicine in 1985. Dr. Brownlow is a member of AAO.

Dr. Brownlow is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.